1. The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome

   • A. O. Shpakov
   • K. V. Derkach

   OriginalPaper 17 May 2017 Pages: 495 - 507

2. Mechanisms of Neuron Loss in Alzheimer’s Disease

   • V. N. Mukhin
   • K. I. Pavlov
   • V. M. Klimenko

   OriginalPaper 16 May 2017 Pages: 508 - 516

3. Changes in Nociceptive Thresholds and Adenylyl Cyclase System Activity in Skeletal Muscles in Rats with Acute and Mild Type 1 Diabetes

   • V. N. Shipilov
   • A. M. Trost
   • A. O. Shpakov

   OriginalPaper 16 May 2017 Pages: 517 - 523

4. Effects of Cold Stress on the Functional Activity of Mouse Peritoneal Macrophages in Conditions of Opiate Receptor Blockade

   • S. V. Gein
   • I. L. Sharav’eva

   OriginalPaper 16 May 2017 Pages: 524 - 527

5. The Mobility of AMPA-Type Glutamate Receptors as a Key Factor in the Expression and Maintenance of Synaptic Potentiation

   • T. A. Zapara
   • A. L. Proskura
   • A. S. Ratushnyak

   OriginalPaper 16 May 2017 Pages: 528 - 533

6. Current Concepts of the Intrathecal Humoral Immune Response and the Diagnostic Significance of the Detection of Oligoclonal Immunoglobulins in Multiple Sclerosis

   • G. S. Makshakov
   • S. V. Lapin
   • E. P. Evdoshenko

   OriginalPaper 16 May 2017 Pages: 534 - 539

7. Potential of Positron Emission Tomography for Studies of the Mechanisms of Development of Multiple Sclerosis (published data and authors’ results)

   • I. D. Stolyarov
   • A. M. Petrov
   • L. N. Prakhova

   OriginalPaper 16 May 2017 Pages: 540 - 543

8. Multiple Sclerosis Disease-Modifying Drugs in Children and Adolescents

   • O. V. Bykova
   • I. A. Nankina
   • A. N. Boiko

   OriginalPaper 17 May 2017 Pages: 544 - 552

9. Treatment with Ex Vivo Expanded Autologous Regulatory CD4⁺CD25⁺Foxp3⁺CD127^low T Cells Restores the Balance of the Immune System in Patients with Remitting Multiple Sclerosis

   • D. D. Eliseeva
   • G. V. Lifshits
   • S. N. Bykovskaya

   OriginalPaper 17 May 2017 Pages: 553 - 560

10. Comparison of the Results of Using β-Interferon-1a Formulations 30 μg for Intramuscular Administration and β-Interferon-1a 44 μg for Subcutaneous Injections in Daily Clinical Practice for the Treatment of Multiple Sclerosis

    • O. G. Borets
    • N. F. Govorukhina
    • A. N. Boiko

    OriginalPaper 17 May 2017 Pages: 561 - 564

11. Results of an Open Prospective Trial of β-Interferon Bioanalogs

    • D. S. Kasatkin
    • N. N. Spirin
    • N. S. Baranova

    OriginalPaper 16 May 2017 Pages: 565 - 569

12. The Potential of Music Therapy in Neurology Using Multiple Sclerosis as an Example

    • E. A. Boiko
    • E. V. Ivanchuk
    • T. T. Batysheva

    OriginalPaper 16 May 2017 Pages: 570 - 572

13. GABA Receptors in the Modulation of Fear Memory Extinction

    • N. I. Dubrovina

    OriginalPaper 16 May 2017 Pages: 573 - 584

14. Microtubule Motor Proteins and the Mechanisms of Synaptic Plasticity

    • N. A. Vasil’eva
    • A. S. Pivovarov

    OriginalPaper 16 May 2017 Pages: 585 - 594

15. Local Protein Synthesis in Dendritic Terminals and Its Regulation in Normal Conditions and during Plastic Changes

    • E. A. Chesnokova
    • P. M. Kolosov

    OriginalPaper 16 May 2017 Pages: 595 - 607

16. Morphometric Evaluation of the Neuroprotective Action of an Extract of Astragalus Membranaceous in the Brains of Rats during Restraint Stress

    • S. M. Gulyaev
    • L. N. Shantanova
    • E. T. Batotsyrenova

    OriginalPaper 16 May 2017 Pages: 608 - 611